Benzinga | Mar 1, 2021 07:06AM EST

Amicus Therapeutics FY 2020 EPS $(1.07) vs $(1.02) Est, Sales $260.9M vs $259.9M Est

Amicus Therapeutics (NASDAQ:FOLD) will report on Q4 2020.